We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×

Continued positive momentum in the second quarter with double-digit revenue growth

Highlights second quarter 2025: • Q2 revenue reached USD 55.3 million, a 12% increase year-over-year, with adjusted EBITDA...

New Platform Unlocks 20 Years of Antarctic Krill Research

A new digital platform with 20 years of research on Antarctic krill and the Southern Ocean has now been launched by Aker...

Aker BioMarine Appoints Bob Nelson as General Manager to its Houston Manufacturing Facility

Through teamwork, performance, and visionary leadership, Nelson sets his sights on “Building for the Future”

Aker BioMarine signs agreement for Lysoveta clinical trial

Oslo, 30 April 2025 – Aker BioMarine has signed an agreement with leading clinical research organization KGK Science Inc.,...

Aker BioMarine Delivers Strong Start to 2025 with Revenue and Earnings Growth

Oslo, 30 April 2025 – Aker BioMarine today reported its financial results for the first quarter of 2025, delivering solid...

Aker BioMarine Partners with Two Distributors to Introduce New Marine Ingredients in Europe

Aker BioMarine is pleased to announce its exclusive partnerships with two European based distributors to launch new marine...

Aker BioMarine Shares Future Trends Shaping the Nutraceuticals Industry in 2025 and Beyond

Oslo, Norway – March 2025 – The global nutraceutical market is on the move and shows no sign of slowing down, driven by...

Aker BioMarine Appoints Jaroslava Juricova-Olsen as CMO for Human Health Ingredients

Oslo, Norway – December 4, 2024 – Aker BioMarine has named Jaroslava Juricova-Olsen as Chief Marketing Officer for its Human...

Krill Oil improve Omega-3 levels in Lupus patients

A new study published in Lupus Science & Medicine found that krill oil supplements (Superba Boost) improved Omega-3 levels...